Our Latest News

Press Releases 31/08/2010

Overdose Awareness Day: Community organisations call for wider availability of naloxone to prevent thousands of unnecessary deaths

Each year thousands of people in Europe and Central Asia lose their lives to drug overdose. The direct provision of naloxone - a safe and highly effective opioid overdose antidote - to people who use drugs could effectively prevent thousands of unnecessary deaths.

Press Releases 07/07/2010

66 countries discriminate against people living with HIV - HIV related entry and residence regulations

Thirty one countries deport foreigners living with HIV+, and 66 countries are known to have specific entry regulations targeting PLHIV, including 16 countries in the WHO Europe region.

Past projects 30/06/2010

AIDS 2010 Vienna - XVIII International AIDS Conference July 18-23 2010

You can find in this page the EATG activities roadmap for the conference.

Other newsletters 24/06/2010

Quick Reference 2010/2011 - Entry and Residence Regulation for people living with HIV

This new issue of the Quick Reference Guide contains all changes on entry regulations for people living with HIV until beginning of 2010 and is based on the results of a new worldwide survey of the foreign representatives of 200 countries, made between November 2007 and June 2008 with the support of the German foreign ministry.

The EATG membership 12/06/2008

Tribute to members no longer with us

EATG is deeply grieved that Roy Arad passed away on June 6, 2010.

Press Releases 19/05/2010

World Hepatitis Day brings long-awaited political recognition of the hepatitis C epidemic

ehrn-logo-en

As the world marks World Hepatitis Day on May 19, the World Health Assembly is expected to adopt the first ever global resolution on viral hepatitis, which will prioritize hepatitis in the work of the World Health Organization and the broader public health community.

Building capacity 10/05/2010

Training materials

In this section you can download the manuals EATG has produced for the trainings on Treatment Literacy and Treatment Advocacy. The manuals are available in English and Russian in electronic and printed format.

russian manual cover

Global HIV News

World Policy 02/09/2010

Sittingbourne man jailed for giving woman HIV

A man who knowingly exposed a woman to the HIV virus has been jailed.

Pharma Industry 02/09/2010

Clinical trials shy away from drug costs

Doctors are increasingly encouraged to factor costs into their drug prescribing decisions but very few clinical trials actually detail these costs, a Canadian study has found.

Hepatitis 02/09/2010

Abbott receives FDA approval for first automated molecular test for assessing hepatitis B treatment

The assay is intended for use as an aid in the management of patients with chronic HBV infection undergoing anti-viral therapy.

Hepatitis 02/09/2010

Inhibitex successfully completes Phase 1a trial of INX-189

Proof-of-concept trial in patients with chronic hepatitis C planned for Q4 2010.

Treatment 02/09/2010

Revaccination could benefit HIV-infected children

HIV-infected children receiving highly active antiretroviral therapy (HAART) may require revaccination to maintain immunity against preventable diseases.

Treatment 02/09/2010

Lab21 launches new commercial companion diagnostic service for HIV tropism in UK

Lab21 will be the first commercial reference laboratory in the UK to provide a companion diagnostic service for the HIV drug, Celsentri, which is marketed by ViiV Healthcare who are currently supporting the provision of this genotypic tropism testing to the UK NHS.

Tuberculosis & Malaria 02/09/2010

New test can diagnose tuberculosis in under 2 hours

A new molecular test for tuberculosis made by Cepheid can diagnose TB and detect a drug-resistant form of it far more easily and rapidly than other tests currently available, scientists said on Wednesday.

Access to treatment 02/09/2010

Drug costs would push millions more into poverty: study

Tens of millions of people in low and middle income countries would be pushed below the poverty line by buying common but vital medicines which are already unaffordable to hundreds of millions more, a study has found.

Print